First-line Treatment of Mantle Cell Lymphoma of Old Patients . Evaluate the Efficacy, Toxicity, and Molecular Prognostic Factors of Velcade®) in Association With Chemotherapy and Immunotherapy With Rituximab
Phase of Trial: Phase II
Latest Information Update: 18 Mar 2016
At a glance
- Drugs Bortezomib (Primary) ; Chlorambucil; Dexamethasone; Doxorubicin; Rituximab
- Indications Mantle-cell lymphoma
- Focus Biomarker; Therapeutic Use
- 10 May 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 10 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.